SHH and cancer: Accumulated evidence has suggested that aberrant activation and dysregulation of Shh signaling was also involved in adult tissues of various cancers, including basal cell carcinoma (BCC), medulloblastoma, lung, pancreatic, gastric, and renal cancers (6, 7).